Quralis Corp., of Cambridge, Mass., raised a seed round extension from new investors, Bioinnovation Capital and Viva Biotech Ltd., which were joined by existing biotech investors, including MP Healthcare Venture Management and Amgen Venture. To date, Quralis has raised $5.5 million.